Editing Sumatriptan (section)

=== Controversy ===
According to the [[American Headache Society]], "Patients frequently state that they have difficulty accessing triptans prescribed to them."<ref name="headache">{{Citation | vauthors=((Minen, M. T.)), ((Lindberg, K.)), ((Langford, A.)), ((Loder, E.)) | year=2017 | title=Variation in Prescription Drug Coverage for Triptans: Analysis of Insurance Formularies | journal=Headache: The Journal of Head and Face Pain | volume=57 | issue=8 | pages=1243–1251 | publisher=Wiley | doi=10.1111/head.13134 | pmid=28691382 | s2cid=42239120 | url=http://dx.doi.org/10.1111/head.13134| url-access=subscription }}</ref> In the U.S. triptans cost from $12 to $120 each, and more than 80% of U.S. health insurance plans place a limit on the amount of pills available to a patient per month, which has been called "arbitrary and unfair."<ref>{{citation |title=Practice Matters Wide Variation in Triptan Coverage Across Commercial and Government Health Plans | vauthors = Bender E |date=7 September 2017 |journal=[[Neurology Today]] |volume=17 |issue=17 |page=7 |publisher=[[American Academy of Neurology]] |doi=10.1097/01.NT.0000524839.20893.03 |s2cid=80167113 |url=https://journals.lww.com/neurotodayonline/fulltext/2017/09070/Practice_Matters__Wide_Variation_in_Triptan.4.aspx |access-date=26 June 2022|url-access=subscription }}</ref>